Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
All reported observations remain confined to preclinical experimental systems and are presented solely for investigational and analytical purposes
Clinical Evidence & Research Findings The published research behind AOD-9604 and Tesamorelin tells two very different stories: AOD-9604s early efficacy signal didnt hold up in its largest trial, while Tesamorelins did which is the central reason one reached FDA approval and the other didnt
Unlike full-length HGH, AOD-9604 has been studied for its ability to selectively influence fat metabolism without affecting blood sugar or cell proliferation markers
There is no evidence that doses above 500mcg produce proportionally better results, and clinical trials using 1mg daily did not dramatically outperform lower doses
Our team of medical professionals will work with you to create a program that is right for you, so you can achieve your goals safely and effectively
Scientists found that in obese mice, MOTS-c treatment reversed diet-induced obesity and insulin resistance the mice shed weight and their blood sugar control improved
